Weekly Futures Recap With Mike Seery

Posted on by The INO.com Team

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Mexican Peso Futures

The Mexican Peso in the September contract settled last Friday at 5462 while currently trading at 5460 basically unchanged for the trading week while trading lower for the 2nd consecutive day down about 50 points this Friday afternoon as I am looking at entering into a bullish position come Monday’s trade. The 10 day low at the present time stands at 5305 which is risking around $900 per contract plus slippage and commission but come Monday’s trade that will be raised to 5358 risking less than $500 per contract plus slippage and commission as I will be patient and look for an entry point come Monday morning. The Peso is trading above its 20 and 100-day moving average telling you that the short-term trend is higher as I think this recent pullback in price is due to the tremendous rally we’ve had in the month of August as I still think the bullish trend is still intact. Continue reading "Weekly Futures Recap With Mike Seery" →

And The Big Winner This Week Is

Posted on by The INO.com Team

Hello MarketClub members everywhere. It's Friday and the big winner for the week is Crude Oil which is up 8.34% for the week and in turn my recommendation to buy Kinder Morgan Inc. (NYSE:KMI).

MarketClub's Mid-day Market Report

Looking at the major indices here are the changes so far this week (Thursday Closes): Continue reading "And The Big Winner This Week Is" →

The Presidential Nominees Are Set

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


The political lines have been drawn, it’s Clinton verses Trump. I written several pieces evaluating the massive sell-offs in the biotech sector. Utilizing the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) as a proxy, I proposed a loose correlation between opportunistic political posturing by political front-runners and the chronic price suppression of IBB. I content that political posturing played a significant role in the sell-off of the healthcare cohort and more specifically biotech stocks. Drug pricing was used as a centerpiece as the scapegoat for political gains. Throughout this political process, this rhetoric has negatively impacted the sector. IBB fell from $401 in July of 2015 to $240 in February of 2016 or alternatively a 40% hit. This sell-off coincided with political rhetoric aimed at the collective cohort of healthcare and biotech companies. I strongly felt that these events were seasonal and would eventually subside without any significant impact to the underlying stocks within IBB. I felt this political induced sell-off presented a great buying opportunity after the 40% decline. I put my money where my mouth was by purchasing two tranches of IBB at a strike price of $250 in February and June during the market-wide sell-off and the Brexit, respectively. I feel that this is great entry point for any long-term investor that desires exposure to the biotechnology sector.

Are Drug Prices Really The Culprit?

In terms of the overall cost to the healthcare system, drugs comprise less than 10% of the pie. Allergan CEO Brent Saunders stated in an interview with Jim Cramer on Mad Money (Figure 1): Continue reading "The Presidential Nominees Are Set" →

BoE Easing Will Be Short-Lived

Posted on by Lior Alkalay

Lior Alkalay - INO.com Contributor - Forex


The UK economy is sending mixed signals of resilient performance and negative sentiment. The latest PMI readings, both in services and manufacturing, plunged below 50, signaling a contraction. Consumer confidence took a nosedive to -12 in July from a -1 reading just a month before. And in the real estate sector, the latest survey of the Royal Institution of Chartered Surveyors of estate agents showed that only 23% of the participants expected housing prices to rise in the next twelve months.

The Bank of England, at its August meeting, responded with sweeping measures to ease monetary conditions. The BoE cut the benchmark interest rate by 25 bps to 0.25%, eased capital requirements for UK banks which will free up £150 billion of liquidity, and the “crown jewel” – a new round of £60 billion in Quantitative Easing, bringing the QE total to £435 billion.

Nevertheless, Key data released in the UK this week suggests that the overall economy is rather resilient, with unemployment holding at 4.9% and core inflation falling only moderately, from 1.4% to 1.3% year-on-year.

So where is UK economy heading? Continue reading "BoE Easing Will Be Short-Lived" →

3 ETFs Every Investor Should Consider Owning

Posted on by Matt Thalman

Matt Thalman - INO.com Contributor - ETFs


Every investor, no matter age, investing experience or portfolio balance should consider putting a large amount of their investable assets in one of these exchange traded funds.

For the majority of investors, the time and energy required to pick individual stocks for their own portfolio's is too much, not to mention the fact that individual stock picking can just be downright overwhelming. The amount of available information and decoding what it all means is very time-consuming and confusing. Plus, the idea that all your hard earned money is tied up in just a few stocks, which at any moment could dramatically lose value, is very frightening.

The best way to avoid the majority of these problems is by simply buying one or more quality exchange traded funds. ETF's offer investors with a very low cost, diverse portfolio and they don't require investors to follow them on a daily, weekly, or even quarterly basis. The right ETF's are really the closest things an investor can find to a "buy and forget about" investment.

Today I would like to talk about three of my favorite ETF's that any investor, no matter their age, income level, size of investment portfolio or investing experience, should consider owning. So let's take a look at what they are. Continue reading "3 ETFs Every Investor Should Consider Owning" →